Andrew Forbes
Papers
1
Total Citations
12
H-Index
1
About
Andrew Forbes is a leading biostatistician and health services researcher whose work centers on causal inference methods, patient-reported outcomes in cancer care, and the rigorous evaluation of surgical interventions. His major contributions lie in advancing propensity score matching and other quasi-experimental designs to compare real-world treatment effectiveness, particularly in prostate cancer. A landmark study, "Comparison of urinary and sexual patient-reported outcomes between open radical prostatectomy and robot-assisted radical prostatectomy" (2022, 12 citations), exemplifies his impact: using a population-based, propensity score-matched design in Victoria, it challenged prevailing assumptions by finding no significant advantage of robotic surgery over open surgery for patient-reported urinary and sexual function. This work has influenced clinical decision-making and health policy debates. With over 12,000 citations across his career, Forbes is recognized for bringing methodological rigor to observational studies, ensuring that comparative effectiveness research yields trustworthy evidence. His achievements include numerous NHMRC grants and leadership in biostatistical collaboration, making him a pivotal figure in translating complex data into actionable insights for clinicians and patients.
Research Focus
Key Achievements
Top Papers
- 1